Skip to main content
Equibles

Millennium Capital Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 2097025 LITTLE ROCK, AR
Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$2,961,551
+$382,338 QoQ
Shares Held
11,769
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#1,661
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Millennium Capital Advisors, LLC holds $10,220,889 across 6 Drug Manufacturers - General names. ABBV ranks #2 (29.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 3,623 $4,345,535
2 ABBV
AbbVie Inc.
This page 		11,769 $2,961,551
3 PFE
Pfizer Inc
 53,877 $1,297,358
4 JNJ
Johnson & Johnson
 3,271 $830,735
5 MRK
Merck & Co., Inc.
 4,450 $571,825
6 BMY
Bristol Myers Squibb Co
 3,712 $213,885

All Filings in ABBV

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,961,551 11,769
2026-03-31 $2,579,213 11,859
2025-12-31 $2,713,318 11,875
2025-09-30 $2,768,060 11,955
2025-06-30 $2,312,639 12,459
2025-03-31 $2,629,476 12,550
2024-12-31 $2,264,431 12,743
2024-09-30 $4,499,186 22,783
2024-06-30 $3,993,843 23,285
2024-03-31 $4,239,652 23,282
2023-12-31 $3,607,546 23,279
2023-09-30 $3,514,238 23,576
2023-06-30 $3,297,920 24,478
2023-03-31 $4,856,163 30,471
2022-12-31 $4,938,478 30,558
2022-09-30 $4,130,178 30,774
2022-06-30 $4,690,984 30,628
2022-03-31 $4,964,132 30,622
2021-12-31 $4,171,267 30,807

Report a Problem

Category
Description
Email (optional, for follow-up)